RPMI-1640完全培养基
RPMI-1640完全培养基由abiowell技术团队精心筛选验证,经过长期测试,本产品可保持多种细胞最佳的生长状态。本产品中已包含细胞生长所需的各种成分,无需额外添加任何成分,可直接用于细胞的体外培养。
01产品图片

02产品简介
RPMI-1640完全培养基由abiowell技术团队精心筛选验证,经过长期测试,本产品可保持多种细胞最佳的生长状态。本产品中已包含细胞生长所需的各种成分,无需额外添加任何成分,可直接用于细胞的体外培养。
03产品介绍
RPMI-1640完全培养基由abiowell技术团队精心筛选验证,经过长期测试,本产品可保持多种细胞最佳的生长状态。本产品中已包含细胞生长所需的各种成分,无需额外添加任何成分,可直接用于细胞的体外培养。
培养基成分RPMI-1640基础培养基+10%FBS+1%P/S 细菌检测阴性真菌检测阴性支原体检测阴性细胞生长试验效果形态正常,生长良好运输条件冰袋冷藏运输存储条件2℃-8℃,避光储存有效期3个月供应限制仅供科研使用
认真做好每一个抗体, 每一个抗体都经过反复验证!
Ovarian cancer (OC) is a significant health challenge, yet the mechanisms driving its progression remain unclear. This study explored the role of hexokinase domain-containing protein 1 (HKDC1) in OC, focusing on tumor growth, lipid metabolism, and immune evasion. Human OC cell lines (SKOV3 and HEY) and the murine OC cell line (ID8) were used to knock down and overexpress HKDC1 . An ID8-based epithelial OC mouse model was established to validate the in vitro findings. Our results demonstrated that HKDC1 was upregulated in OC and promoted cell proliferation, migration, and invasion. HKDC1 enhanced lipid accumulation by elevating levels of free fatty acids (FFA), triglycerides, phospholipids, cholesterol, and neutral lipid, while upregulating key enzymes (ACC1, FASN, SCD1, HMGCS1, and HMGCR). It promoted immune escape through PD-L1 upregulation, inhibiting T cell proliferation and reducing IFN-γ, granzyme B, and perforin levels while increasing PD-1 levels. HKDC1 knockdown reversed these effects, which were restored by adding FFA. Mechanistically, HKDC1 interacted with and stabilized glucose-6-phosphatase catalytic subunits (G6PC/G6PC2), supporting its tumor-promoting functions. These findings were confirmed in an OC mouse model, highlighting HKDC1 as a key driver of OC progression through lipid biosynthesis and immune suppression, offering potential therapeutic targets.
Authors:Wang Ying, Chen Juan, Wang Zhan, Luo Xia, Wu Nayiyuan, Wang Jing
Background Lung adenocarcinoma (LUAD) is a prevalent subtype of lung cancer (LC) whose progression is regulated by multiple genes. This study sought to find the impact and mechanism of HNRNPH1 on LUAD. Methods The expression and role of HSP90AB1, HNRNPH1, and autophagy-related protein MAP1LC3B in LUAD were detected. Additionally, bioinformatics analysis, silencing and overexpression techniques, and in vivo modeling were used to explore the regulatory mechanisms of these proteins in the progression of LUAD. Results HSP90AB1 showed high expression in LUAD and was linked to a worse prognosis. Overexpression of HSP90AB1 significantly promoted the malignant phenotype of LUAD cells and inhibited MAP1LC3B-mediated autophagy. However, overexpression of HNRNPH1 could reverse the malignant phenotype resulting from HSP90AB1 overexpression and promote MAP1LC3B-mediated autophagy by binding to HSP90AB1 mRNA and inhibiting its protein expression. Animal experiments also revealed that overexpression of HNRNPH1 could inhibit tumor progression by promoting cellular autophagy. Conclusions We verified the key role of HSP90AB1, HNRNPH1, and MAP1LC3B in LUAD, and revealed a possible regulatory mechanism, namely, HNRNPH1 could inhibit the development of LUAD by promoting autophagy through the HSP90AB1/MAP1LC3B axis. These findings may offer new insights for improving the treatment and prognosis of LUAD. Clinical trial number Not applicable.
Authors:Li Rong, Li Fen, Liu Qian, Wu Xu, Tan Xiaowu Authors:Changze Ou, Zheng-ping Bai, Guo-heng Hu, Binbin Chen, Da-hua Wu, Hua-jun Long Authors:Aijun Jia, Yueling Wang, Rimei Zhou, Likun Han TOXICOLOGY AND APPLIED PHARMACOLOGY IF:3.6
Bone is a primary site for lung cancer metastasis, and T-box transcription factor 15 (Tbx15) is aberrantly expressed in multiple cancers. It aims to investigate the role of Tbx15 in lung cancer bone metastasis and its potential mechanisms. TCGA and cellular analyses revealed elevated Tbx15 lung adenocarcinoma tissues and cells (MLE-12, CMT64, LA795, LLC), while recombinant IL-25 (rIL-25) expression was low in supernatants and lysates. And Pearson analysis showed a negative correlation between Tbx15 and IL-25. The CCK-8 and EdU assays showed that Tbx15 knockdown inhibited LA795 cell proliferation, migration, and invasion. In vivo , simultaneous Tbx15 knockdown and rIL-25 administration promote tumor cell growth and accelerate bone metastasis in mice. Mechanistically, Tbx15 knockdown upregulates IL-25 expression, thereby promoting apoptosis of osteoclasts (OCs) and suppressing bone metastasis. Besides, OCs were treated with rIL-25 and the apoptosis inhibitor Z -VAD-FMK, and found that extracellular IL-25 protein promoted apoptosis of OCs by upregulating major vault protein (MVP) expression. In conclusion, our study demonstrates that knockdown of Tbx15 upregulates IL-25 expression to promote apoptosis of OCs, while exogenous supplementation of IL-25 promotes proliferation and bone metastasis of lung adenocarcinoma cells. The dual role of IL-25 in Tbx15-positive lung adenocarcinoma cells and its potential regulatory mechanism were elucidated.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY IF:3.4 Authors:Fenfen Zhan, Ronghui Zhang, Lanlan Qiu, Yuezhong Ren APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY IF:3.3 Immunity Inflammation and Disease IF:3.1 BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS IF:2.9 Authors:Danfei Zhou, Jun Ying, Haijian Liu, Shanshan Hu, Jiangdong Li, Jiaojiao Ren AML12细胞专用培养基由abiowell技术团队精心筛选验证,经过长期测试,本产品可保持AML12细胞最佳的生长状态。本产品中已包含AML12细胞生长所需的各种成分,无需额外添加任何成分,可直接用于AML12细胞的体外培养。
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2016 年
- 所在地
- 湖南
- 收录条目
- 498 个
- 平台核验
- 平台代管
06品牌与供应商
公司产品涵盖抗体、细胞、培养基、质粒载体等多个领域,致力于为生命科学研究提供可靠的工具与解决方案。自创立以来,艾碧维始终秉持“求实、诚挚、勤勉、克己”的发展理念,坚持以自主研发与持续创新为核心动力。公司拥有百余人的团队,其中硕士及以上学历生物医学专业人才占比超过30%,包括博士4人,构建起一支结构合理、专业扎实的研发与服务队伍。通过设立研发部、生产部、市场与营销部、财务部等多功能部门,公司实现了从产品开发到市场推广的全流程管控。艾碧维不仅敢于质疑现状,积极为生命科学家突破技术壁垒提供支撑,更注重与客户的深度互动与合作,通过持续收集反馈、开展研发协作,提前预见并解决潜在问题。未来,公司将继续秉持“助力科研创新,让实验更简单”的使命,一步一个脚印地打造具有国际领先水平的技术研发与产业化平台,为全球生命科学领域的进步持续赋能。注意: 1.本公司产品仅供科研使用。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
艾碧维 在本目录共 498 个条目,除本条外还有:
科研在线(TeleVM). RPMI-1640完全培养基(AW-MC002)[EB/OL]. 产品目录, 2026-10-31. https://www.suprotek.cn/products/item/aw-mc002.html.
TeleVM. (2026, October 31). RPMI-1640完全培养基(AW-MC002). 产品目录. https://www.suprotek.cn/products/item/aw-mc002.html
@misc{biocsp_item_aw_mc002,
title = {RPMI-1640完全培养基(AW-MC002)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-10-31,产品目录},
url = {https://www.suprotek.cn/products/item/aw-mc002.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源